Dyne Therapeutics, Inc. Common Stock
Symbol: DYN (NASDAQ)
13.41
▼ (-3.70%) -0.515
Company Description:
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Key Stats
- Today's Open: $13.92
- Today's High: $14.05
- Today's Low: $13.064
- Today's Volume: 6.63M
- Yesterday Close: $13.92
- Yesterday High: $13.98
- Yesterday Low: $13.21
- Yesterday Volume: 1.95M
- Last Min Volume: 74
- Last Min High: $13.405
- Last Min Low: $13.405
- Last Min VWAP: $13.405
Company Profile
- Name: Dyne Therapeutics, Inc. Common Stock
- Website: https://www.dyne-tx.com
- Listed Date: 2020-09-17
- Location: WALTHAM, MA
- Market Status: Active
- CIK Number: 0001818794
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $1.87B
- Round Lot: 100
- Outstanding Shares: 142.26M
- Asset Type: CS
RECENT FILINGS FOR DYN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-09-05 | 144 | View |
| 2025-09-04 | 144 | View |
| 2025-08-07 | SCHEDULE 13G/A | View |
| 2025-08-04 | 8-K | View |
| 2025-07-28 | 8-K | View |
| 2025-07-28 | 10-Q | View |
| 2025-07-18 | 4 | View |
| 2025-07-18 | 4 | View |
| 2025-07-18 | 4 | View |
| 2025-07-15 | 4 | View |
| 2025-07-01 | 424B5 | View |
| 2025-07-01 | 8-K | View |
| 2025-06-30 | 424B5 | View |
| 2025-06-30 | 8-K | View |
| 2025-06-17 | 8-K | View |
| 2025-06-11 | 144 | View |
| 2025-06-11 | 144 | View |
Latest News on DYN